Coronary Artery Disease Clinical Trial
Official title:
Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment
This study will test the accuracy of magnetic resonance imaging (MRI) in measuring cardiac
perfusion (blood flow). MRI of the heart can measure blood flow to heart muscle, but
collateral coronary arteries (vessels that supply blood to the heart muscle) may reduce the
accuracy of the measurements. This study will perform special measurements of coronary artery
flow and pressure in patients undergoing heart catheterization and catheter-based treatment
(angioplasty and stenting) in order to compare for accuracy with cardiac MRI.
Patients 21 years of age and older with coronary artery blockage may be eligible for this
study. All participants undergo cardiac MRI, to produce images of the heart, as well as
special invasive blood flow testing during heart catheterization, angioplasty, and stenting.
During MRI, the subject lies on a table that can slide in and out of the scanner (a narrow
cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the
scanning process. The procedure lasts about 45 to 90 minutes. Since the heart moves during
breathing, subjects are asked to hold their breath intermittently for about 5-20 seconds. A
medicine called dipyridamole is injected through a vein in the subject's arm to increase
blood flow to the coronary arteries and help detect blockages. Pictures are taken of the
heart before, during, and after the dipyridamole injection. Another medicine called
gadolinium is also given through a vein. This medicine brightens the images to measure blood
flow.
During a separate catheterization, angioplasty, and stenting procedure, subjects undergo
additional invasive tests. The additional tests use a special guidewire to measure coronary
artery pressure and blood flow, as well as a special ultrasound to look inside the artery.
Patients have a repeat MRI about 2 months after the catheterization.
Cardiac magnetic resonance imaging (MRI) can measure perfusion (blood flow) to heart muscle.
Collateral coronary arteries (natural bypasses to the heart) may reduce the accuracy of
perfusion measured by cardiac MRI.
We are testing the accuracy of these measurements in subjects undergoing medically necessary
cardiac catheterization and catheter-based treatment (angioplasty and stenting). We will
perform special invasive measurements of coronary artery flow and pressure during
catheterization in order to compare with cardiac MRI.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
| Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
| Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
| Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
| Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
| Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
| Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
| Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
| Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
| Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |